Detailed price information for Precipio Inc (PRPO-Q) from The Globe and Mail including charting and trades.
Goldman Sachs, RTX and Abbott lead Zacks' latest research, with growth drivers balanced by costs, supply-chain and market risks.
PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.
Detailed price information for Precipio Inc (PRPO-Q) from The Globe and Mail including charting and trades.
Moby summary of Precipio, Inc.'s Q2 2026 earnings call
Detailed price information for Precipio Inc (PRPO-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.